GlassScriptPhysician profile
Mathew A Thomas
NPI 1225234891
$4,575.02
in general payments reported to CMS, 2019-2025
10 companies · $14.27 in 2025
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.77 · 2021: $4,337 · 2023: $163 · 2024: $23.58 · 2025: $14.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microaire Surgical Instruments LLC | $4,300.00 | 2021 | |
| Abbvie INC. | $74.94 | 2023-2024 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $62.70 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Organogenesis INC. | $36.57 | 2021 | |
| Axogen | $22.15 | 2023 | Avance Nerve Graft |
| Linvatec Corporation | $20.88 | 2023 | Linvatec Video Accessories |
| Stryker Corporation | $16.46 | 2023 | Variax, Swanson |
| International Rehabilitative Sciences, INC | $14.27 | 2025 | Rs-4i Plus With Intersperse |
| Vapotherm INC | $14.00 | 2023 | Vapotherm |
| Pacira Pharmaceuticals Incorporated | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.